Is a complete ENGN research report available?

No complete published report is available for enGene Therapeutics Inc. (ENGN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

enGene Therapeutics Inc. (ENGN)

NASDAQ: ENGN · USD

$1.82

-0.07 (-3.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ENGN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	121.9M
Net income (ttm)	-126.9M
EPS (ttm)	-$2.12
Shares out	67M
Volume	665,801
Beta	-0.27
Price target	$3.29	+80.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -126.9M
EPS (ttm): -$2.12
Market cap: 121.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ENGN indicators

Market & fundamental data

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001980845
Company name	enGene Therapeutics Inc.
Country	Canada
Country code	US
Cusip	29286X101
Employees	82
Employees Change	25%
Employees Change Percent	43.86
Enterprise value	$-103.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	CA29286X1015
Last refreshed	2026-07-25
Market cap	$121.9M
Market cap category	Micro-Cap
Price	$1.82
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2836
Symbol	ENGN
Website	https://www.engene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-104.04%
FCF yield	-91.36%
P/B ratio	0.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-126.9M
Net Income Growth Years	0%
Profit Per Employee	$-1.5M
ROA	-28.86
ROCE	-46.35
ROE	-52.58
ROIC	-30.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-52.26%
Cagr3y	-44.71%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$307.5M
Cash	$258.5M
Current Assets	$270M
Current Liabilities	$21.5M
Debt	$33.4M
Debt Equity	$0.13
Equity	$255.2M
Interest Coverage	-44.42
Liabilities	$52.4M
Long Term Assets	$37.5M
Long Term Liabilities	$30.9M
Net Cash	$225.1M
Net Cash By Market Cap	$185
Net Cash Growth	17.23%
Net Debt Equity	$-0.88
Tangible Book Value	$255.2M
Tangible Book Value Per Share	$3.81
WACC	3.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.57
Net Working Capital	$-7.5M
Quick ratio	12.17
Working Capital	$248.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-25.52%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-52.23%
200-day SMA	6.55
3Y total return	-83.1%
50-day SMA	1.76
50-day SMA vs 200-day SMA	50under200
All Time High	47.17
All Time High Change	-96.14%
All Time High Date	2023-10-26
All Time Low	1.4
All Time Low Change	30%
All Time Low Date	2026-05-12
ATR	0.12
Beta	-0.27
Beta1y	1.24
Beta2y	0.51
Ch YTD	-79.84
High	1.89
High52	12.25
High52 Date	2026-01-23
High52ch	-85.14%
Low	1.81
Low52	1.4
Low52 Date	2026-05-12
Low52ch	30%
Ma50ch	3.47%
Price vs 200-day SMA	-72.2%
RSI	42.98
RSI Monthly	36.15
RSI Weekly	32.4
Sharpe ratio	0.37x
Sortino ratio	0.51
Total Return	-25.52%
Tr YTD	-79.84
Tr1m	6.43%
Tr3m	-77.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	8
Analyst Price Target Top	$7.33
Analyst Ratings	Hold
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.44
Operating Income	$-132.6M
Price target	$3.29
Price Target Change	$80.77
Price Target Change Top	$303

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,122,536%
Float Percent	28.55%
Net Borrowing	1,248,000
Shares Insiders	0.67%
Shares Institutions	38.66%
Shares Out	66,989,466
Shares Qo Q	3.66%
Shares Yo Y	25.52%
Short Float	5.97%
Short Ratio	1.15
Short Shares	1.7

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-123.5M
Average Volume	1,033,337.1x
Bv Per Share	3.81
CAPEX	$-1.4M
Ch1m	6.43
Ch1y	-52.23
Ch3m	-77.64
Ch3y	-83.1
Ch6m	-85.05
Change	-3.7%
Change From Open	-3.7
Close	1.89
Days Gap	0
Depreciation Amortization	670,000
Dollar Volume	1,211,757.8
Earnings Date	2026-09-10
Earnings Time	amc
EBIT	$-132.6M
EBITDA	$-131.9M
EPS	$-2.12
F Score	1
FCF	$-111.4M
FCF EV Yield	107.94x
FCF Per Share	$-1.66
Financing CF	143,058,000
Fiscal Year End	October
Founded	1,999
Income Tax	$-258,000
Investing CF	-60,780,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-06-15
Last Report Date	2026-04-30
Last Split Type	Never
Last10k Filing Date	2025-12-22
Ma150	6.11
Ma150ch	-70.2%
Ma20	1.85
Ma20ch	-1.78%
Net CF	-27,718,000
Next Earnings Date	2026-09-10
Open	1.89
Optionable	Yes
Position In Range	12.5
Post Close	1.82
Postmarket Change Percent	1.92
Postmarket Price	$1.86
Ppne	9,440,000
Price Date	2026-07-24
Ptbv Ratio	0.48
Relative Volume	0.64x
Share Based Comp	12,135,000
Tr6m	-85.05%
Volume	665,801

enGene Therapeutics Inc. (ENGN)

Coverage state: Market snapshot only — no published research

Generate the first ENGN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ENGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ENGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ENGN

Frequently asked questions